3rd Quarter - Report

KING & SPALDING LLP for KANEKA PHARMA AMERICA, LLC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Advocacy in support of Medicare coverage for Dialysis-Related Amyloidosis (DRA) Treatment

Foreign entity interest: Kaneka Corporation, as identified on the LD-1, has an interest in the issues listed above as the owner of Kaneka Pharma America, LLC.

LobbyistCovered position, as disclosed
MICHAEL A ANDREWS —
JEANNINE M BENDER Staff, Rep. Barton
WILLIAM CLARKSON Leg. Asst. Sen. Collins; Staff Asst. Sen. Coverdell
ALEXANDER ("ANDER") M. CRENSHAW U.S. Representative (FL-04), 2001-2017
DAVID JOSEPH FARBER —
ALLISON F KASSIR —
PREEYA NORONHA PINTO Deputy GC, Principal Deputy GC, Acting GC, HHS

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.